UBC Faculty Research and Publications

An Effective and Safe Enkephalin Analog for Antinociception Viswanadham, K. K. DurgaRao; Böttger, Roland; Hohenwarter, Lukas; Nguyen, Anne; Rouhollahi, Elham; Smith, Alexander D.; Tsai, Yi-Hsuan; Chang, Yuan-Yu; Ortiz, Christopher Llynard; Yang, Lee-Wei; Jimenez, Liliana; Li, Siyuan; Hur, Chan; Li, Shyh-Dar

Abstract

Opioids account for 69,000 overdose deaths per annum worldwide and cause serious side effects. Safer analgesics are urgently needed. The endogenous opioid peptide Leu-Enkephalin (Leu-ENK) is ineffective when introduced peripherally due to poor stability and limited membrane permeability. We developed a focused library of Leu-ENK analogs containing small hydrophobic modifications. N-pivaloyl analog KK-103 showed the highest binding affinity to the delta opioid receptor (68% relative to Leu-ENK) and an extended plasma half-life of 37 h. In the murine hot-plate model, subcutaneous KK-103 showed 10-fold improved anticonception (142%MPE·h) compared to Leu-ENK (14%MPE·h). In the formalin model, KK-103 reduced the licking and biting time to ~50% relative to the vehicle group. KK-103 was shown to act through the opioid receptors in the central nervous system. In contrast to morphine, KK-103 was longer-lasting and did not induce breathing depression, physical dependence, and tolerance, showing potential as a safe and effective analgesic.

Item Media

Item Citations and Data

License

CC BY 4.0

Usage Statistics